STRATTERA Not Withdrawn for Safety or Effectiveness

The FDA determined that STRATTERA (atomoxetine hydrochloride) capsules at all dosage strengths (5mg through 100mg) were not withdrawn from sale for reasons of safety or effectiveness. This determination allows generic drug manufacturers to reference this finding in abbreviated new drug applications (ANDAs) without providing separate safety and effectiveness data.

Icebreaker Collaboration Effort (ICE) Pact Request for Information

The Maritime Administration (MARAD) published a Request for Information (RFI) seeking public input on the Icebreaker Collaboration Effort (ICE) Pact, a potential initiative for collaboration on icebreaker ship construction. The agency is soliciting feedback from industry stakeholders, shipbuilders, and other interested parties. The comment period closes on June 5, 2026.

FTZ 21 Production Activity - Turbocam Turbine Components

The Foreign-Trade Zones Board published notice 91 FR 17245 requesting public comment on Turbocam Inc.'s proposed production activity at FTZ 21 in Ladson, South Carolina. The company seeks authority to manufacture turbine system components under the FTZ program. The Board invites public comments on the proposed activity.

Bank Control Notice Correction Regarding Share Acquisitions

The Federal Reserve published a correction to its Change in Bank Control Notices regarding acquisitions of shares of banks and bank holding companies. The document (91 FR 17278) corrects errors in a previously published notice. This is a routine correction with no new regulatory requirements or substantive changes to existing policy.

Bank Holding Company Formations, Acquisitions, and Mergers

The Federal Reserve System published a notice listing recent formations of bank holding companies and acquisitions/mergers approved or processed under the Bank Holding Company Act. This routine notice provides public awareness of ownership changes in the banking sector. No specific transactions, deadlines, or penalties are detailed in this notice.

PIC/S GMP Guide Revised Chapters 3, 5, 8 and Annex 17

PIC/S has revised Chapters 3, 5, 8 and Annex 17 of the GMP Guide (PE 009-14), aligning them with EU GMP principles and Quality Risk Management. Key changes include new cross-contamination prevention requirements in Chapters 3 and 5, updated supplier qualification requirements, and expanded quality defect evaluation expectations in Chapter 8. The revision entered into force on 1 July 2018.

Proposed Collection Under Paperwork Reduction Act

The U.S. Army Department published a Federal Register notice seeking public comments on a proposed information collection under the Paperwork Reduction Act. The notice provides a 62-day comment period ending June 5, 2026. This is a standard administrative procedure for federal agencies to solicit input on planned data collection activities.

Defense Health Agency Proposed Information Collection Request

The Defense Health Agency published a Federal Register notice announcing a proposed information collection request and soliciting public comments. The notice indicates a 62-day comment period. DHA is seeking input from affected parties before proceeding with the collection under the Paperwork Reduction Act.

DoD Wage Committee announces federal advisory committee meetings

The DoD Wage Committee published a notice announcing upcoming federal advisory committee meetings. The notice covers sessions scheduled in March and April 2026, including one meeting on March 17, 2026 that was already held and closed to the public. The meetings fall under the Federal Advisory Committee Act framework.

Form GC-859 Nuclear Fuel Data Collection Extension

The Energy Information Administration (EIA) published a Federal Register notice seeking public comment on extending the information collection for Form GC-859, Nuclear Fuel Data. This form collects data on nuclear fuel supply, acquisition, fabrication, inventory, and high-level radioactive waste from nuclear power plants. The comment period closes on May 6, 2026.